What are pharma companies’ expectations for pre-competitive research?

Edition

What are pharma companies’ expectations for pre-competitive research?

Precompetitive collaboration provides a means to rapidly develop new capabilities and research outcomes. This session aims to provide valuable insights into the needs and aspirations of pharma companies when it comes to pre-competitive partnerships and how they align with other stakeholders. What are the current challenges and knowledge gaps they aim to address through collaborative efforts? What are the alternatives to large consortia? Are there new ways of financing pre-competitive research? What are pharma companies’ rationale and benefits at this stage? What are the specific areas of research and priority topics of interest? What are the considerations around IP and data sharing? What are the key factors for successful outcomes in pre-competitive research collaborations?

Moderator: Matthieu Flourakis, Team Lead Business Innovation & Senior Project Manager, Akkodis Belgium

Iraida Soria Espinosa

Senior Innovation and Business Manager
United Kingdom
UK Dementia Research Institute

Jürgen Bauer

Deputy Managing Director
Germany
EMBLEM Technology Transfer

Joachim Vogt

Director, Search and Evaluation International
Germany
AbbVie

Anette Sommer

Senior Director, Emerging Science & Innovation (ES&I) – Lead Oncology Europe
Germany
Pfizer
Scroll to Top
  • No products in the cart.